1 day Ago By ABMN Staff
Wells Fargo & Company MN boosted its position in STERIS plc ( NYSE:STE – Free Report ) by 0.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 88,360 shares of the medical equipment provider’s stock after acquiring an additional 394 shares during the period.
Wells Fargo & Company MN owned 0.09% of STERIS worth $18,163,000 at the end of the most recent reporting period. Other hedge funds have also recently modified their holdings of the company.
Avalon Trust Co purchased a new position in shares of STERIS during the fourth quarter valued at approximately $30,000. Human Investing LLC bought a new position in STERIS in the 4th quarter worth $31,000. Anfield Capital Management LLC lifted its position in shares of STERIS by 100.
0% in the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after purchasing an additional 91 shares during the period. Central Pacific Bank Trust Division boosted its stake in shares of STERIS by 65.
5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock valued at $39,000 after purchasing an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC increased its position in shares of STERIS by 182.
7% during the fourth quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after buying an additional 137 shares during the period. Hedge funds and other institutional investors own 94.
69% of the company’s stock. Wall Street Analysts Forecast Growth STE has been the topic of several research reports. Stephens reaffirmed an “overweight” rating and set a $240.
00 price objective on shares of STERIS in a research report on Thursday, February 6th. Needham & Company LLC restated a “hold” rating on shares of STERIS in a research report on Monday, April 7th. Piper Sandler increased their price objective on STERIS from $260.
00 to $265.00 and gave the stock an “overweight” rating in a report on Monday, February 3rd. Finally, JMP Securities reissued a “market outperform” rating and set a $265.
00 price objective on shares of STERIS in a research report on Thursday. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $258.
75. STERIS Stock Up 1.9 % STE stock opened at $221.
18 on Monday. The company has a quick ratio of 1.40, a current ratio of 2.
13 and a debt-to-equity ratio of 0.32. The business has a 50 day moving average of $222.
61 and a 200 day moving average of $219.50. STERIS plc has a twelve month low of $197.
82 and a twelve month high of $248.24. The firm has a market cap of $21.
73 billion, a PE ratio of 46.96 and a beta of 0.87.
STERIS ( NYSE:STE – Get Free Report ) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share for the quarter, missing the consensus estimate of $2.
33 by ($0.01). STERIS had a net margin of 8.
66% and a return on equity of 13.91%. On average, research analysts forecast that STERIS plc will post 9.
08 EPS for the current fiscal year. STERIS Dividend Announcement The company also recently declared a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were issued a dividend of $0.
57 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.
03%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS’s payout ratio is 48.
41%. STERIS Profile ( Free Report ) STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental.
The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services. Recommended Stories Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter .
.
